Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: A controlled study

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 8, 2010, Pages 897-903

  Leibovici, V ^a   Canetti, L ^b   Yahalomi, S ^a   Cooper Kazaz, R ^a   Bonne, O ^a   Ingber, A ^a   Bachar, E ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

atopic dermatitis; psoriasis; psychopathology

Indexed keywords

ADJUSTMENT TO CHRONIC SKIN DISEASES QUESTIONNAIRE; ADULT; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; HAND TEST; HUMAN; INTERMETHOD COMPARISON; ISRAEL; MALE; MENTAL DISEASE; MENTAL HEALTH INVENTORY; OUTPATIENT DEPARTMENT; PERSONALITY TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; SKIN DISEASE; STIGMA;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANXIETY; CASE-CONTROL STUDIES; DEPRESSION; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PSORIASIS; QUALITY OF LIFE; RISK FACTORS; SELF REPORT;

EID: 77954411031     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03542.x     Document Type: Article

References (56)

1. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004 9 : 136 139.
2. Blauvelt A. New concepts in the pathogenesis and treatment of psoriasis: key roles for IL-23,IL-17A and TGF-beta 1. Expert Rev Dermatol 2007 2 : 69 78.
3. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002 22 : 1 24.
4. Schmitt J, Bauer A, Meurer M. Atopic eczema in adulthood. Hautarzt 2008 59 : 841 850.
5. Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006 126 : 1200 1202.
6. Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen Hosp Psychiatry 1987 9 : 157 166.
7. Ginsburg IH. Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995 13 : 793 803.
8. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms and interventions. Dermatol Clin 2005 23 : 681 694.
9. Shuster S, Fisher GH, Harris E et al. The effect of skin disease on self image. Br J Dermatol 1978 99 : 18 19.
10. Leichtman SR, Burnett JW, Robinson HM Jr. Body image concerns of psoriasis patients as reflected in human figure drawings. J Pers Assess 1981 45 : 478 484.
11. Weinstein MZ. Psychosocial perspectives on psoriasis. Dermatol Clin 1984 2 : 507 515.
12. Jobling R. Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976 1 : 233 236.
13. Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985 20 : 425 429.
14. Akay A, Pekcanlar A, Bozdag KE et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002 16 : 347 352.
15. Devrimci-Ozguven H, Kundakci TN, Kumbasar H et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000 14 : 267 271.
16. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998 139 : 846 850.
17. Gupta MA, Gupta AK, Kirby S et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988 124 : 1052 1057.
18. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998 61 : 339 342.
19. Richards HL, Fortune DG, Griffiths CE et al. The contribution of perceptions of stigmatization to disability in patients with psoriasis. J Psychosom Res 2001 50 : 11 15.
20. Hammerlid E, Ahlner-Elmqvist M, Bjordal K et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999 80 : 766 774.
21. Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003 15 : 532 549.
22. Susskind W, McGuire RJ. The emotional factor in psoriasis. Scott Med J 1959 4 : 503 507.
23. Gilbert AR, Rodgers DA, Roenigk HH Jr. Personality evaluation in psoriasis. Cleve Clin Q 1973 40 : 147 152.
24. Baugham R, Sobel R. Psoriasis, stress, and strain. Arch Dermatol 1971 103 : 599 605.
25. Seville RH. Psoriasis and stress. Br J Dermatol 1977 97 : 297 302.
26. Arnetz BB, Fjellner B, Eneroth P et al. Stress and psoriasis psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985 47 : 528 541.
27. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001 70 : 6 16.
28. Gupta MA, Gupta AK, Schork NJ et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994 56 : 36 40.
29. Jordan JM, Whitlock FA. Atopic dermatitis, anxiety and conditioned scratch responses. J Psychosom Res 1974 18 : 297 299.
30. Brown DG. Stress as a precipitant factor of eczema. J Psychosom Res 1972 16 : 321 327.
31. Lammintausta K, Kalimo K, Raitala R et al. Prognosis of atopic dermatitis. A prospective study in early adulthood. Int J Dermatol 1991 30 : 563 568.
32. King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991 35 : 697 706.
33. Gil KM, Keefe FJ, Sampson HA et al. The relation of stress and family environment to atopic dermatitis symptoms in children. J Psychosom Res 1987 31 : 673 684.
34. Schmitt J, Romanos M, Schmitt NM et al. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 2009 301 : 724 726.
35. Veit CT, Ware JE. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol 1983 51 : 730 742.
36. Guy W. ECDEU. Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare Publication ADM 76-338. National Institute of Mental Health
37. Wagner EE. The Hand Test: Manual. Western Psychological Services
38. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978 157 : 238 244.
39. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD Index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 186 : 23 31.
40. Vardy D, Besser A, Amir M et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002 147 : 736 742.
41. Porter JR, Beuf AH, Lerner A et al. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986 15 : 220 224.
42. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007 445 : 648 651.
43. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008 181 : 7420 7427.
44. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007 25 : 529 534.
45. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 32 : 982 986.
46. Kimball AB, Robinson D Jr., Wu Y et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases. Dermatology 2008 217 : 27 37.
47. Mallbris L, Granath F, Hamsten A et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006 54 : 614 621.
48. Dreiher J, Weitzman D, Cohen AD. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 2009 129 : 1643 1649.
49. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 1741.
50. Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 2008 59 : 10 17.
51. Sterry W, Strober BE, Menter A. International Psoriasis Council. Br J Dermatol 2007 157 : 649 655.
52. Lewitus GM, Wilf-Yarkoni A, Ziv Y et al. Vaccination as a novel approach for treating depressive behavior. Biol Psychiatry 2009 65 : 283 288.
53. Yu B, Becnel J, Zerfaoui M, Rohatgi R et al. Serotonin 5-hydroxitryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency. J Pharmacol Exp Ther 2008 327 : 316 323.
54. Krishnan R, Cella D, Leonardi C et al. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 2007 157 : 1275 1277.
55. Bassukas ID, Hyphantis T, Gamvroulia C et al. Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity. J Eur Acad Dermatol Veneorol 2008 22 : 257 258.
56. Menter A, Signorovitch I, Gupta S et al. Adalimumab reduces symptoms of depression in patients with moderate to severe psoriasis. Poster Presented at the 67th Annual Meeting of the American Academy of Dermatology, March 6-10, 2009